Search by Drug Name or NDC

    NDC 76329-8261-01 Lorazepam 2 mg/mL Details

    Lorazepam 2 mg/mL

    Lorazepam is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by International Medication Systems, Limited. The primary component is LORAZEPAM.

    Product Information

    NDC 76329-8261
    Product ID 76329-8261_ac83af71-9706-477f-8d49-01dc8553a052
    Associated GPIs 57100060002005
    GCN Sequence Number 003755
    GCN Sequence Number Description lorazepam VIAL 2 MG/ML INJECTION
    HIC3 H21
    HIC3 Description SEDATIVE-HYPNOTICS - BENZODIAZEPINES
    GCN 14140
    HICL Sequence Number 004846
    HICL Sequence Number Description LORAZEPAM
    Brand/Generic Generic
    Proprietary Name Lorazepam
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lorazepam
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 2
    Active Ingredient Units mg/mL
    Substance Name LORAZEPAM
    Labeler Name International Medication Systems, Limited
    Pharmaceutical Class Benzodiazepine [EPC], Benzodiazepines [CS]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA076150
    Listing Certified Through 2024-12-31

    Package

    NDC 76329-8261-01 (76329826101)

    NDC Package Code 76329-8261-1
    Billing NDC 76329826101
    Package 10 VIAL in 1 CARTON (76329-8261-1) / 10 mL in 1 VIAL
    Marketing Start Date 2012-12-01
    NDC Exclude Flag N
    Pricing Information N/A